CD44 and lung adenocarcinoma: Immunocytochemical staining of the respective CSC markers in the well-established lung adenocarcinoma-derived cell line LXF-289 revealed no expression for cancer stem cell markers CD133 and Nestin and only low expression of CD44 in comparison to LCSC-like cells (Figure 2M,N).